Quarta-Rad, Inc., a company specializing in the distribution of detection devices and AI-enhanced video analytics services, has released its Form 10-Q report for the third quarter. The report provides a detailed overview of the company's financial performance and operational highlights, shedding light on the challenges and opportunities faced during the period.
Financial Highlights
- Sales: $301,061, representing a 51.95% decrease compared to the same period in 2022, primarily due to reduced sales of the RD1503 model.
- Gross Profit: $128,274, reflecting a decrease in cost of goods sold, which was down by 57.88% due to reduced revenue.
- Net Income: $20,321, an increase of $60,138 compared to a net loss in the previous year, primarily due to a decrease in unrecognized gain on investments.
- Sales (Three months ended June 30, 2023): $102,082, a decrease of 71.01% compared to the same period in 2022, attributed to lower demand for the RD1503 model.
- Gross Profit (Three months ended June 30, 2023): $52,591, reflecting a significant reduction in cost of goods sold due to decreased sales volume.
Business Highlights
- Revenue Segments: The company operates through two segments, Quarta-Rad and Sellavir. Quarta-Rad focuses on distributing detection devices, while Sellavir provides AI-enhanced video analytics services. Quarta-Rad's revenue decreased significantly due to reduced demand for the RD1503 model, while Sellavir saw a slight increase in revenue due to the timing of recognized revenue.
- Geographical Performance: The company holds exclusive distribution rights for QRR products in Europe, the US, and Asia (excluding China). However, the UK retail platform was suspended due to restrictions, and efforts are underway to lift these restrictions and explore new EU distribution partners.
- Sales Units: The company continues to focus on direct-to-consumer sales through the Internet and third-party resellers. The sales strategy includes promoting detection products to home renovation contractors and other purchasers.
- Future Outlook: The company plans to increase revenues with additional working capital and expand its reseller network by targeting large consumer retail chains. It also intends to leverage Sellavir's AI capabilities to enhance its Radex series and expand beyond radiation measurement.
SEC Filing: